Guangzhou, China, March. 1, 2021  — TMFOX VENTURE PARTNERS, a boutique investment bank and venture investor for global healthcare announces that it has entered into an exclusive financial advisory agreement with Guangzhou Rongli Bio-Medical Co.,ltd for its estimated 6 million USD fundraising.  

Commenting on the agreement, Dr.Yong Yang, Founder of Rongli, said, “We are delighted to work with TMFOX toward these great objectives With the joint efforts of our two companies, we are confident tremendous success will be achieved and significant benefits will be delivered to people who love the beauty.”

About Guangzhou Rongli

Guangzhou Rongli Biotechnology Co., Ltd. has a construction area of ​​38 acres and a factory production area of ​​11,000 square meters. It has a second-class medical device business license, a “machine name” product production license, and a disinfection product production license. The product is safe and effective Sex is guaranteed.

About TMFOX VENTURE PARTNERS

TMFOX focuses on the evolution of global Healthcare and is committed to empowering its clients with cross-border funding, business development, and risk management. TMFOX offers holistic solutions that help clients grow competitive in this constantly evolving market. Founded in 2009 in Shenzhen in China by Andy Yu, the boutique investment bank has operations in 6 cities across China and 3 international cities such as Vancouver, Seattle, and Boston in North American.